Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.

Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

The stock has lagged behind the Dow over the longer term as well. ELV stock has declined 16.7% on a YTD basis and 18.5% over the past 52 weeks compared to DOWI’s 18.8% gains in 2024 and 23.9% ...

For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per ...

The Dow Jones Industrial Average (DJIA) is slipping today despite investors preparing for the upcoming Federal Reserve meeting. Traders have been waiting for this meeting as it will be a major ...

Shares of Elevance Health Inc. ELV shed 0.61% ... with the S&P 500 Index SPX falling 1.07% to 5,906.94 and Dow Jones Industrial Average DJIA falling 0.97% to 42,573.73. This was the stock's ...